Adam Halberstadt

Title(s)Associate Adjunct Professor, Psychiatry
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California San DiegoPost-doc2012Psychopharmacology
    University of PittsburghPh.D.2006Neurobiology
    University of DelawareB.A.1998Biology, Psychology
    Collapse Awards and Honors
    NIDA2009  - 2012F32 NRSA post-doctoral fellowship
    NIDCD2004  - 2006Individual F31 NRSA predoctoral fellowship
    NIMH2014  - 2016K01 Career Development Award
    International Society for Serotonin Research2013  - 2020Associate Councilor
    Serotonin Club2008Travel Award
    American College of Neuropsychopharmacology2011Travel Award
    American College of Neuropsychopharmacology2018Associate Member

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    The Next Generation of Hallucinogens: A New Class of Synthetic Psychoactive Drugs
    NIH R01DA041336Feb 15, 2017 - Dec 31, 2020
    Role: Principal Investigator
    Role of the prefrontal cortex in serotonergic modulation of interval timing
    NIH K01MH100644Jan 9, 2014 - Dec 31, 2016
    Role: Principal Investigator
    Mechanisms of hallucinogen effects on exploratory behavior in rats and mice
    NIH F32DA025412May 1, 2009 - Apr 30, 2012
    Role: Principal Investigator
    Raphe Nuclei Projections to Vestibular Nuclei
    NIH F31DC006772Jul 4, 2004 - Jul 3, 2006
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Analytical and behavioral characterization of 1-dodecanoyl-LSD (1DD-LSD). Drug Test Anal. 2024 Apr 03. Kavanagh PV, Westphal F, Pulver B, Elliott SP, Stratford A, Halberstadt AL, Brandt SD. PMID: 38569566.
      View in: PubMed   Mentions:
    2. Serotonin-2 Receptor Agonists Produce Anti-inflammatory Effects through Functionally Selective Mechanisms That Involve the Suppression of Disease-Induced Arginase 1 Expression. ACS Pharmacol Transl Sci. 2024 Feb 09; 7(2):478-492. Flanagan TW, Foster TP, Galbato TE, Lum PY, Louie B, Song G, Halberstadt AL, Billac GB, Nichols CD. PMID: 38357283; PMCID: PMC10863441.
      View in: PubMed   Mentions:
    3. Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential. Nat Commun. 2023 Dec 15; 14(1):8221. Wallach J, Cao AB, Calkins MM, Heim AJ, Lanham JK, Bonniwell EM, Hennessey JJ, Bock HA, Anderson EI, Sherwood AM, Morris H, de Klein R, Klein AK, Cuccurazzu B, Gamrat J, Fannana T, Zauhar R, Halberstadt AL, McCorvy JD. PMID: 38102107; PMCID: PMC10724237.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    4. Identification of 5-HT2A Receptor Signaling Pathways Responsible for Psychedelic Potential. bioRxiv. 2023 Jul 31. Wallach J, Cao AB, Calkins MM, Heim AJ, Lanham JK, Bonniwell EM, Hennessey JJ, Bock HA, Anderson EI, Sherwood AM, Morris H, de Klein R, Klein AK, Cuccurazzu B, Gamrat J, Fannana T, Zauhar R, Halberstadt AL, McCorvy JD. PMID: 37577474; PMCID: PMC10418054.
      View in: PubMed   Mentions:
    5. Analytical and behavioral characterization of N-ethyl-N-isopropyllysergamide (EIPLA), an isomer of N6 -ethylnorlysergic acid N,N-diethylamide (ETH-LAD). Drug Test Anal. 2024 Feb; 16(2):187-198. Brandt SD, Kavanagh PV, Westphal F, Pulver B, Schwelm HM, Stratford A, Auwärter V, Halberstadt AL. PMID: 37321559.
      View in: PubMed   Mentions: Translation:HumansAnimals
    6. Mu-opioid receptor selective superagonists produce prolonged respiratory depression. iScience. 2023 Jul 21; 26(7):107121. Malcolm NJ, Palkovic B, Sprague DJ, Calkins MM, Lanham JK, Halberstadt AL, Stucke AG, McCorvy JD. PMID: 37416459; PMCID: PMC10320493.
      View in: PubMed   Mentions: 2  
    7. A non-hallucinogenic LSD analog with therapeutic potential for mood disorders. Cell Rep. 2023 03 28; 42(3):112203. Lewis V, Bonniwell EM, Lanham JK, Ghaffari A, Sheshbaradaran H, Cao AB, Calkins MM, Bautista-Carro MA, Arsenault E, Telfer A, Taghavi-Abkuh FF, Malcolm NJ, El Sayegh F, Abizaid A, Schmid Y, Morton K, Halberstadt AL, Aguilar-Valles A, McCorvy JD. PMID: 36884348; PMCID: PMC10112881.
      View in: PubMed   Mentions: 18     Fields:    Translation:Animals
    8. Use of the head-twitch response to investigate the structure-activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines. Psychopharmacology (Berl). 2022 Dec 07. Halberstadt AL, Luethi D, Hoener MC, Trachsel D, Brandt SD, Liechti ME. PMID: 36477925.
      View in: PubMed   Mentions:    Fields:    
    9. Analytical profile of the lysergamide 1cP-AL-LAD and detection of impurities. Drug Test Anal. 2023 Mar; 15(3):277-291. Kavanagh PV, Westphal F, Pulver B, Schwelm HM, Stratford A, Auwärter V, Chapman SJ, Halberstadt AL, Brandt SD. PMID: 36321499.
      View in: PubMed   Mentions:
    10. Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD. Drug Test Anal. 2022 Aug; 14(8):1503-1518. Brandt SD, Kavanagh PV, Westphal F, Pulver B, Schwelm HM, Whitelock K, Stratford A, Auwärter V, Halberstadt AL. PMID: 35524430; PMCID: PMC9546273.
      View in: PubMed   Mentions: 2  Translation:HumansAnimals
    11. Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1-valeroyl-d-lysergic acid diethylamide (1V-LSD). Drug Test Anal. 2022 Apr; 14(4):733-740. Brandt SD, Kavanagh PV, Westphal F, Pulver B, Morton K, Stratford A, Dowling G, Halberstadt AL. PMID: 34837347; PMCID: PMC9191648.
      View in: PubMed   Mentions: 3  Translation:Animals
    12. HIV Transgenic Rats Demonstrate Impaired Sensorimotor Gating But Are Insensitive to Cannabinoid (Δ9-Tetrahydrocannabinol)-Induced Deficits. Int J Neuropsychopharmacol. 2021 11 12; 24(11):894-906. Roberts BZ, Minassian A, Halberstadt AL, He YV, Chatha M, Geyer MA, Grant I, Young JW. PMID: 34338765; PMCID: PMC8598295.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    13. (2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice. Neuropsychopharmacology. 2022 03; 47(4):914-923. Rudin D, McCorvy JD, Glatfelter GC, Luethi D, Szöllosi D, Ljubišic T, Kavanagh PV, Dowling G, Holy M, Jaentsch K, Walther D, Brandt SD, Stockner T, Baumann MH, Halberstadt AL, Sitte HH. PMID: 34750565; PMCID: PMC8882185.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    14. Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity. J Nat Prod. 2021 04 23; 84(4):1403-1408. Fricke J, Sherwood AM, Halberstadt AL, Kargbo RB, Hoffmeister D. PMID: 33667102; PMCID: PMC9191645.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    15. International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. Pharmacol Rev. 2021 01; 73(1):310-520. Barnes NM, Ahern GP, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S, Claeysen S, Cunningham KA, Fone KC, Gershon M, Di Giovanni G, Goodfellow NM, Halberstadt AL, Hartley RM, Hassaine G, Herrick-Davis K, Hovius R, Lacivita E, Lambe EK, Leopoldo M, Levy FO, Lummis SCR, Marin P, Maroteaux L, McCreary AC, Nelson DL, Neumaier JF, Newman-Tancredi A, Nury H, Roberts A, Roth BL, Roumier A, Sanger GJ, Teitler M, Sharp T, Villalón CM, Vogel H, Watts SW, Hoyer D. PMID: 33370241; PMCID: PMC7770494.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    16. Investigation of the Structure-Activity Relationships of Psilocybin Analogues. ACS Pharmacol Transl Sci. 2021 Apr 09; 4(2):533-542. Klein AK, Chatha M, Laskowski LJ, Anderson EI, Brandt SD, Chapman SJ, McCorvy JD, Halberstadt AL. PMID: 33860183; PMCID: PMC8033608.
      View in: PubMed   Mentions: 34  
    17. Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison. Schizophr Bull. 2020 12 01; 46(6):1396-1408. Leptourgos P, Fortier-Davy M, Carhart-Harris R, Corlett PR, Dupuis D, Halberstadt AL, Kometer M, Kozakova E, LarØi F, Noorani TN, Preller KH, Waters F, Zaytseva Y, Jardri R. PMID: 32944778; PMCID: PMC7707069.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    18. Response to Mukhdomi and Mukhdomi's letter to the editor. Reg Anesth Pain Med. 2021 06; 46(6):557-558. Castellanos JP, Woolley C, Bruno KA, Zeidan F, Halberstadt A, Furnish T. PMID: 33033159.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Analytical profile of N-ethyl-N-cyclopropyl lysergamide (ECPLA), an isomer of lysergic acid 2,4-dimethylazetidide (LSZ). Drug Test Anal. 2020 Oct; 12(10):1514-1521. Brandt SD, Kavanagh PV, Westphal F, Stratford A, Elliott SP, Dowling G, Halberstadt AL. PMID: 32803833; PMCID: PMC9191644.
      View in: PubMed   Mentions: 1  Translation:Cells
    20. Acute serotonin 2A receptor activation impairs behavioral flexibility in mice. Behav Brain Res. 2020 10 01; 395:112861. Amodeo DA, Hassan O, Klein L, Halberstadt AL, Powell SB. PMID: 32814148.
      View in: PubMed   Mentions: 10     Fields:    Translation:Animals
    21. Syntheses and analytical characterizations of novel (2-aminopropyl)benzo[b]thiophene (APBT) based stimulants. Drug Test Anal. 2020 Aug; 12(8):1109-1125. Brandt SD, Carlino L, Kavanagh PV, Westphal F, Dreiseitel W, Dowling G, Baumann MH, Sitte HH, Halberstadt AL. PMID: 32372465; PMCID: PMC8281332.
      View in: PubMed   Mentions:
    22. Automated detection of the head-twitch response using wavelet scalograms and a deep convolutional neural network. Sci Rep. 2020 05 20; 10(1):8344. Halberstadt AL. PMID: 32433580; PMCID: PMC7239849.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    23. Chronic pain and psychedelics: a review and proposed mechanism of action. Reg Anesth Pain Med. 2020 07; 45(7):486-494. Castellanos JP, Woolley C, Bruno KA, Zeidan F, Halberstadt A, Furnish T. PMID: 32371500.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    24. Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD). Drug Test Anal. 2020 Jun; 12(6):812-826. Brandt SD, Kavanagh PV, Westphal F, Stratford A, Odland AU, Klein AK, Dowling G, Dempster NM, Wallach J, Passie T, Halberstadt AL. PMID: 32180350; PMCID: PMC9191646.
      View in: PubMed   Mentions: 7  Translation:Animals
    25. Investigation of the 2,5-Dimethoxy Motif in Phenethylamine Serotonin 2A Receptor Agonists. ACS Chem Neurosci. 2020 05 06; 11(9):1238-1244. Marcher-Rørsted E, Halberstadt AL, Klein AK, Chatha M, Jademyr S, Jensen AA, Kristensen JL. PMID: 32212672.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    26. The selective 5-HT2A receptor agonist 25CN-NBOH: Structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H]25CN-NBOH. Biochem Pharmacol. 2020 07; 177:113979. Jensen AA, Halberstadt AL, Märcher-Rørsted E, Odland AU, Chatha M, Speth N, Liebscher G, Hansen M, Bräuner-Osborne H, Palner M, Andreasen JT, Kristensen JL. PMID: 32298690.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    27. Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin. J Nat Prod. 2020 02 28; 83(2):461-467. Sherwood AM, Halberstadt AL, Klein AK, McCorvy JD, Kaylo KW, Kargbo RB, Meisenheimer P. PMID: 32077284.
      View in: PubMed   Mentions: 28     Fields:    Translation:AnimalsCells
    28. Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. Neuropharmacology. 2020 05 01; 167:107933. Halberstadt AL, Chatha M, Klein AK, Wallach J, Brandt SD. PMID: 31917152; PMCID: PMC9191653.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansAnimals
    29. Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD). Neuropharmacology. 2020 08 01; 172:107856. Halberstadt AL, Chatha M, Klein AK, McCorvy JD, Meyer MR, Wagmann L, Stratford A, Brandt SD. PMID: 31756337; PMCID: PMC9191647.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    30. DARK Classics in Chemical Neuroscience: NBOMes. ACS Chem Neurosci. 2020 Dec 02; 11(23):3860-3869. Poulie CBM, Jensen AA, Halberstadt AL, Kristensen JL. PMID: 31657895; PMCID: PMC9191638.
      View in: PubMed   Mentions: 19     Fields:    
    31. Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD). Drug Test Anal. 2019 Aug; 11(8):1122-1133. Brandt SD, Kavanagh PV, Westphal F, Stratford A, Elliott SP, Dowling G, Wallach J, Halberstadt AL. PMID: 31083768; PMCID: PMC6899222.
      View in: PubMed   Mentions: 13  Translation:Animals
    32. Pharmacological characterizations of the 'legal high' fluorolintane and isomers. Eur J Pharmacol. 2019 Aug 15; 857:172427. Wallach J, Colestock T, Agramunt J, Claydon MDB, Dybek M, Filemban N, Chatha M, Halberstadt AL, Brandt SD, Lodge D, Bortolotto ZA, Adejare A. PMID: 31152702; PMCID: PMC6899220.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    33. Convergent neural substrates of inattention in bipolar disorder patients and dopamine transporter-deficient mice using the 5-choice CPT. Bipolar Disord. 2020 02; 22(1):46-58. Young JW, Geyer MA, Halberstadt AL, van Enkhuizen J, Minassian A, Khan A, Perry W, Eyler LT. PMID: 31025493; PMCID: PMC6815232.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    34. 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α2-adrenergic receptors. Psychopharmacology (Berl). 2019 Mar; 236(3):989-999. Halberstadt AL, Brandt SD, Walther D, Baumann MH. PMID: 30904940; PMCID: PMC6848746.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    35. Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice. J Psychopharmacol. 2019 03; 33(3):406-414. Halberstadt AL, Chatha M, Chapman SJ, Brandt SD. PMID: 30789291; PMCID: PMC6848748.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    36. Correction to: Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA). Psychopharmacology (Berl). 2019 02; 236(2):809. Halberstadt AL, Klein LM, Chatha M, Valenzuela LB, Stratford A, Wallach J, Nichols DE, Brandt SD. PMID: 30443792.
      View in: PubMed   Mentions:    Fields:    
    37. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen. Psychopharmacology (Berl). 2019 Feb; 236(2):821-830. Halberstadt AL, van der Zee JVF, Chatha M, Geyer MA, Powell SB. PMID: 30448990; PMCID: PMC6778591.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    38. Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran ("FLY") and benzodifuran ("DragonFLY") analogs. Neuropharmacology. 2019 01; 144:368-376. Halberstadt AL, Chatha M, Stratford A, Grill M, Brandt SD. PMID: 30385253; PMCID: PMC6863604.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    39. Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA). Psychopharmacology (Berl). 2019 02; 236(2):799-808. Halberstadt AL, Klein LM, Chatha M, Valenzuela LB, Stratford A, Wallach J, Nichols DE, Brandt SD. PMID: 30298278; PMCID: PMC6848745.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    40. Measuring Gratitude in Children. J Posit Psychol. 2019; 14(5):563-575. Hussong AM, Langley HA, Thomas T, Coffman J, Halberstadt A, Costanzo P, Rothenberg WA. PMID: 31467585; PMCID: PMC6715141.
      View in: PubMed   Mentions: 3  
    41. Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs. Neuropharmacology. 2018 11; 142:231-239. Klein LM, Cozzi NV, Daley PF, Brandt SD, Halberstadt AL. PMID: 29499272; PMCID: PMC6230509.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    42. Effect of Hallucinogens on Unconditioned Behavior. Curr Top Behav Neurosci. 2018; 36:159-199. Halberstadt AL, Geyer MA. PMID: 28224459; PMCID: PMC5787039.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimals
    43. Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775). Drug Test Anal. 2018 Feb; 10(2):310-322. Brandt SD, Kavanagh PV, Twamley B, Westphal F, Elliott SP, Wallach J, Stratford A, Klein LM, McCorvy JD, Nichols DE, Halberstadt AL. PMID: 28585392; PMCID: PMC6230476.
      View in: PubMed   Mentions: 24  Translation:HumansAnimals
    44. Return of the lysergamides. Part III: Analytical characterization of N6 -ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD). Drug Test Anal. 2017 Oct; 9(10):1641-1649. Brandt SD, Kavanagh PV, Westphal F, Elliott SP, Wallach J, Stratford A, Nichols DE, Halberstadt AL. PMID: 28342178; PMCID: PMC6230477.
      View in: PubMed   Mentions: 14  Translation:HumansPHPublic Health
    45. Hallucinogenic Drugs: A New Study Answers Old Questions about LSD. Curr Biol. 2017 02 20; 27(4):R156-R158. Halberstadt AL. PMID: 28222297.
      View in: PubMed   Mentions: 1     Fields:    
    46. Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens. Curr Top Behav Neurosci. 2017; 32:283-311. Halberstadt AL. PMID: 28097528.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimals
    47. Premature responses in the five-choice serial reaction time task reflect rodents' temporal strategies: evidence from no-light and pharmacological challenges. Psychopharmacology (Berl). 2016 Oct; 233(19-20):3513-25. Cope ZA, Halberstadt AL, van Enkhuizen J, Flynn AD, Breier M, Swerdlow NR, Geyer MA, Young JW. PMID: 27534540; PMCID: PMC5023490.
      View in: PubMed   Mentions: 27     Fields:    Translation:Animals
    48. Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues. PLoS One. 2016; 11(6):e0157021. Wallach J, Kang H, Colestock T, Morris H, Bortolotto ZA, Collingridge GL, Lodge D, Halberstadt AL, Brandt SD, Adejare A. PMID: 27314670; PMCID: PMC4912077.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimals
    49. Return of the lysergamides. Part II: Analytical and behavioural characterization of N6 -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ). Drug Test Anal. 2017 Jan; 9(1):38-50. Brandt SD, Kavanagh PV, Westphal F, Elliott SP, Wallach J, Colestock T, Burrow TE, Chapman SJ, Stratford A, Nichols DE, Halberstadt AL. PMID: 27265891; PMCID: PMC5411264.
      View in: PubMed   Mentions: 22  Translation:HumansAnimals
    50. Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice. Pharmacol Biochem Behav. 2016 09; 148:69-75. Halberstadt AL, Hyun J, Ruderman MA, Powell SB. PMID: 27236030; PMCID: PMC5662292.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    51. Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives. Drug Test Anal. 2017 Jan; 9(1):115-126. Brandt SD, Kavanagh PV, Dowling G, Talbot B, Westphal F, Meyer MR, Maurer HH, Halberstadt AL. PMID: 27100373; PMCID: PMC5412731.
      View in: PubMed   Mentions: 3  
    52. BDNF-Deficient Mice Show Reduced Psychosis-Related Behaviors Following Chronic Methamphetamine. Int J Neuropsychopharmacol. 2016 Apr; 19(4). Manning EE, Halberstadt AL, van den Buuse M. PMID: 26453694; PMCID: PMC4851263.
      View in: PubMed   Mentions: 18     Fields:    Translation:Animals
    53. Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice. Neuropharmacology. 2016 08; 107:364-375. Halberstadt AL, Sindhunata IS, Scheffers K, Flynn AD, Sharp RF, Geyer MA, Young JW. PMID: 27020041; PMCID: PMC5403251.
      View in: PubMed   Mentions: 20     Fields:    Translation:Animals
    54. Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine. Pharmacol Biochem Behav. 2016 Apr; 143:1-10. Halberstadt AL. PMID: 26780349; PMCID: PMC5403252.
      View in: PubMed   Mentions: 14     Fields:    Translation:Animals
    55. The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents. Psychopharmacology (Berl). 2016 Apr; 233(7):1215-25. Halberstadt AL, Slepak N, Hyun J, Buell MR, Powell SB. PMID: 26758284; PMCID: PMC5403250.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    56. Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD). Drug Test Anal. 2016 Sep; 8(9):891-902. Brandt SD, Kavanagh PV, Westphal F, Stratford A, Elliott SP, Hoang K, Wallach J, Halberstadt AL. PMID: 26456305; PMCID: PMC4829483.
      View in: PubMed   Mentions: 29  Translation:Animals
    57. N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues. ACS Chem Neurosci. 2015 Jul 15; 6(7):1165-75. Nichols DE, Sassano MF, Halberstadt AL, Klein LM, Brandt SD, Elliott SP, Fiedler WJ. PMID: 25547199; PMCID: PMC4505863.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    58. Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behav Brain Res. 2015 Jan 15; 277:99-120. Halberstadt AL. PMID: 25036425; PMCID: PMC4642895.
      View in: PubMed   Mentions: 101     Fields:    Translation:HumansAnimals
    59. PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program. J Psychoactive Drugs. 2014 Jan-Mar; 46(1):73-7. Greer GR, Grob CS, Halberstadt AL. PMID: 24830188.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimals
    60. Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder. J Affect Disord. 2014 Feb; 155:247-54. van Enkhuizen J, Geyer MA, Halberstadt AL, Zhuang X, Young JW. PMID: 24287168; PMCID: PMC3924859.
      View in: PubMed   Mentions: 23     Fields:    Translation:Animals
    61. Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response. Neuropharmacology. 2014 Feb; 77:200-7. Halberstadt AL, Geyer MA. PMID: 24012658; PMCID: PMC3866097.
      View in: PubMed   Mentions: 48     Fields:    Translation:Animals
    62. Hippocampal serotonin depletion unmasks differences in the hyperlocomotor effects of phencyclidine and MK-801: quantitative versus qualitative analyses. Front Pharmacol. 2013; 4:109. Adams WK, Halberstadt AL, van den Buuse M. PMID: 24009584; PMCID: PMC3756227.
      View in: PubMed   Mentions: 4  
    63. Serotonergic hallucinogens as translational models relevant to schizophrenia. Int J Neuropsychopharmacol. 2013 Nov; 16(10):2165-80. Halberstadt AL, Geyer MA. PMID: 23942028; PMCID: PMC3928979.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimals
    64. The role of PKC signaling in CRF-induced modulation of startle. Psychopharmacology (Berl). 2013 Oct; 229(4):579-89. Toth M, Gresack JE, Hauger RL, Halberstadt AL, Risbrough VB. PMID: 23722830; PMCID: PMC3784645.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    65. Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement. Psychopharmacology (Berl). 2013 Jun; 227(4):727-39. Halberstadt AL, Geyer MA. PMID: 23407781; PMCID: PMC3866102.
      View in: PubMed   Mentions: 84     Fields:    Translation:Animals
    66. Role of the 5-HT₂A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice. Neuropharmacology. 2013 Jul; 70:218-27. Halberstadt AL, Powell SB, Geyer MA. PMID: 23376711; PMCID: PMC3934507.
      View in: PubMed   Mentions: 21     Fields:    Translation:Animals
    67. A novel visuospatial priming task for rats with relevance to Tourette syndrome and modulation of dopamine levels. Neurosci Biobehav Rev. 2013 Jul; 37(6):1139-49. Amitai N, Weber M, Swerdlow NR, Sharp RF, Breier MR, Halberstadt AL, Young JW. PMID: 23010529; PMCID: PMC3556379.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    68. Four factors underlying mouse behavior in an open field. Behav Brain Res. 2012 Jul 15; 233(1):55-61. Tanaka S, Young JW, Halberstadt AL, Masten VL, Geyer MA. PMID: 22569582; PMCID: PMC3866095.
      View in: PubMed   Mentions: 38     Fields:    Translation:Animals
    69. Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated rats. Pharmacol Biochem Behav. 2012 Jul; 102(1):88-94. Halberstadt AL, Buell MR, Price DL, Geyer MA. PMID: 22487771; PMCID: PMC3354037.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    70. Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor. Psychopharmacology (Berl). 2012 Jun; 221(4):709-18. Halberstadt AL, Nichols DE, Geyer MA. PMID: 22222861; PMCID: PMC3796951.
      View in: PubMed   Mentions: 19     Fields:    Translation:Animals
    71. Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: implications for schizophrenia. Neuropharmacology. 2011 Jul-Aug; 61(1-2):209-16. van den Buuse M, Ruimschotel E, Martin S, Risbrough VB, Halberstadt AL. PMID: 21501627; PMCID: PMC3866100.
      View in: PubMed   Mentions: 19     Fields:    Translation:Animals
    72. Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology. 2011 Sep; 61(3):364-81. Halberstadt AL, Geyer MA. PMID: 21256140; PMCID: PMC3110631.
      View in: PubMed   Mentions: 132     Fields:    Translation:HumansAnimalsCells
    73. Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice. Psychopharmacology (Berl). 2011 May; 215(1):81-92. Halberstadt AL, Lehmann-Masten VD, Geyer MA, Powell SB. PMID: 21153406; PMCID: PMC3072483.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    74. Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice. J Psychopharmacol. 2011 Nov; 25(11):1548-61. Halberstadt AL, Koedood L, Powell SB, Geyer MA. PMID: 21148021; PMCID: PMC3531560.
      View in: PubMed   Mentions: 64     Fields:    Translation:Animals
    75. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry. 2011 Jan; 68(1):71-8. Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, Greer GR. PMID: 20819978.
      View in: PubMed   Mentions: 272     Fields:    Translation:Humans
    76. (Muller CP, Jacobs B Eds.), Handbook of the Behavioral Neurobiology of Serotonin. Serotonin and serotonin receptors in hallucinogen action. 2010; 585-620. Halberstadt AL, Nichols DE.
    77. (Muller CP, Jacobs B Eds.), Handbook of the Behavioral Neurobiology of Serotonin. Serotonin and schizophrenia. 2010; 621-636. Quednow BB, Geyer MA, Halberstadt AL .
    78. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor. Psychopharmacology (Berl). 2010 Feb; 208(2):179-89. Halberstadt AL, Geyer MA. PMID: 19937319; PMCID: PMC2797624.
      View in: PubMed   Mentions: 32     Fields:    Translation:Animals
    79. 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice. Neuropsychopharmacology. 2009 Jul; 34(8):1958-67. Halberstadt AL, van der Heijden I, Ruderman MA, Risbrough VB, Gingrich JA, Geyer MA, Powell SB. PMID: 19322172; PMCID: PMC2697271.
      View in: PubMed   Mentions: 76     Fields:    Translation:AnimalsCells
    80. Habituation and sensitization of acoustic startle: opposite influences of dopamine D1 and D2-family receptors. Neurobiol Learn Mem. 2009 Sep; 92(2):243-8. Halberstadt AL, Geyer MA. PMID: 18644244; PMCID: PMC2745310.
      View in: PubMed   Mentions: 19     Fields:    Translation:Animals
    81. Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors. Psychopharmacology (Berl). 2008 Nov; 201(1):55-66. Halberstadt AL, Buell MR, Masten VL, Risbrough VB, Geyer MA. PMID: 18604652; PMCID: PMC2929165.
      View in: PubMed   Mentions: 26     Fields:    Translation:Animals
    82. Projections from the vestibular nuclei and nucleus prepositus hypoglossi to dorsal raphe nucleus in rats. Neurosci Lett. 2008 Jul 04; 439(1):70-4. Cuccurazzu B, Halberstadt AL. PMID: 18511198; PMCID: PMC2459230.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    83. Selective anterograde tracing of nonserotonergic projections from dorsal raphe nucleus to the basal forebrain and extended amygdala. J Chem Neuroanat. 2008 Jul; 35(4):317-25. Halberstadt AL, Balaban CD. PMID: 18434087; PMCID: PMC2442033.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    84. Selective anterograde tracing of the individual serotonergic and nonserotonergic components of the dorsal raphe nucleus projection to the vestibular nuclei. Neuroscience. 2007 Jun 15; 147(1):207-23. Halberstadt AL, Balaban CD. PMID: 17507165; PMCID: PMC2093990.
      View in: PubMed   Mentions: 17     Fields:    Translation:Animals
    85. Anterograde tracing of projections from the dorsal raphe nucleus to the vestibular nuclei. Neuroscience. 2006 Dec 01; 143(2):641-54. Halberstadt AL, Balaban CD. PMID: 16989955.
      View in: PubMed   Mentions: 13     Fields:    Translation:Animals
    86. Serotonergic and nonserotonergic neurons in the dorsal raphe nucleus send collateralized projections to both the vestibular nuclei and the central amygdaloid nucleus. Neuroscience. 2006 Jul 07; 140(3):1067-77. Halberstadt AL, Balaban CD. PMID: 16600519.
      View in: PubMed   Mentions: 28     Fields:    Translation:AnimalsCells
    87. Organization of projections from the raphe nuclei to the vestibular nuclei in rats. Neuroscience. 2003; 120(2):573-94. Halberstadt AL, Balaban CD. PMID: 12890525.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    88. The phencyclidine-glutamate model of schizophrenia. Clin Neuropharmacol. 1995 Jun; 18(3):237-49. Halberstadt AL. PMID: 8635182.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    Adam's Networks
    Concepts (287)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (18)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California